Adrienne L. Watson

992 total citations
22 papers, 663 citations indexed

About

Adrienne L. Watson is a scholar working on Neurology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Adrienne L. Watson has authored 22 papers receiving a total of 663 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Neurology, 10 papers in Pulmonary and Respiratory Medicine and 8 papers in Molecular Biology. Recurrent topics in Adrienne L. Watson's work include Neurofibromatosis and Schwannoma Cases (11 papers), Sarcoma Diagnosis and Treatment (10 papers) and Neuroblastoma Research and Treatments (4 papers). Adrienne L. Watson is often cited by papers focused on Neurofibromatosis and Schwannoma Cases (11 papers), Sarcoma Diagnosis and Treatment (10 papers) and Neuroblastoma Research and Treatments (4 papers). Adrienne L. Watson collaborates with scholars based in United States, Hong Kong and Spain. Adrienne L. Watson's co-authors include David A. Largaespada, Nancy Ratner, Eric P. Rahrmann, Margaret H. Collins, Vincent W. Keng, Christopher L. Moertel, Branden S. Moriarity, Daniel F. Carlson, Scott C. Fahrenkrug and Kwangmin Choi and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Genetics and Bioinformatics.

In The Last Decade

Adrienne L. Watson

21 papers receiving 652 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Adrienne L. Watson United States	14	310	247	160	81	70	22	663
Nikola Holtkamp Germany	19	350 1.1×	341 1.4×	240 1.5×	88 1.1×	56 0.8×	27	814
Jussara Hagen United States	14	604 1.9×	165 0.7×	110 0.7×	234 2.9×	79 1.1×	20	855
Jan Gronych Germany	11	466 1.5×	138 0.6×	49 0.3×	102 1.3×	74 1.1×	17	706
Claudia Tessmer Germany	8	271 0.9×	93 0.4×	106 0.7×	71 0.9×	78 1.1×	17	677
Suzanne E. Little United Kingdom	14	538 1.7×	153 0.6×	164 1.0×	138 1.7×	101 1.4×	15	847
Barbara R. Tschida United States	13	482 1.6×	93 0.4×	69 0.4×	108 1.3×	104 1.5×	19	705
Tanya Basu United Kingdom	7	191 0.6×	380 1.5×	134 0.8×	88 1.1×	32 0.5×	18	686
Ludger Klewes Canada	15	437 1.4×	139 0.6×	35 0.2×	80 1.0×	47 0.7×	18	634
Sybil M. Genther Williams United States	7	430 1.4×	111 0.4×	71 0.4×	215 2.7×	64 0.9×	8	781
Anita Olofsson Sweden	10	382 1.2×	152 0.6×	184 1.1×	61 0.8×	14 0.2×	10	615

Countries citing papers authored by Adrienne L. Watson

Since Specialization

Citations

This map shows the geographic impact of Adrienne L. Watson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Adrienne L. Watson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Adrienne L. Watson more than expected).

Fields of papers citing papers by Adrienne L. Watson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Adrienne L. Watson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Adrienne L. Watson. The network helps show where Adrienne L. Watson may publish in the future.

Co-authorship network of co-authors of Adrienne L. Watson

This figure shows the co-authorship network connecting the top 25 collaborators of Adrienne L. Watson. A scholar is included among the top collaborators of Adrienne L. Watson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Adrienne L. Watson. Adrienne L. Watson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Tschida, Barbara R., Maryam Aftabizadeh, Eric C. Holland, et al.. (2025). Abstract 6511: Immunocompetent large animal model of mesenchymal glioblastoma achieved through somatic gene editing technology. Cancer Research. 85(8_Supplement_1). 6511–6511.

Kirstein, Mark N., James Fisher, Christopher L. Moertel, et al.. (2023). Combining nonsense mutation suppression therapy with nonsense-mediated decay inhibition in neurofibromatosis type 1. Molecular Therapy — Nucleic Acids. 33. 227–239. 5 indexed citations

Watson, Adrienne L., et al.. (2022). MODL-15. BRINGING PRECISION MEDICINE TO GLIOBLASTOMA PATIENTS BY MODELING MOLECULAR TUMOR SUBTYPES IN IMMUNOCOMPETENT SWINE FOR THERAPEUTIC AND BIOMARKER DEVELOPMENT. Neuro-Oncology. 24(Supplement_7). vii294–vii294. 1 indexed citations

Kaiser, Robert A., Daniel F. Carlson, Dennis A. Webster, et al.. (2021). Development of a porcine model of phenylketonuria with a humanized R408W mutation for gene editing. PLoS ONE. 16(1). e0245831–e0245831. 8 indexed citations

Watson, Adrienne L., et al.. (2021). Neurofibromatosis in the Era of Precision Medicine: Development of MEK Inhibitors and Recent Successes with Selumetinib. Current Oncology Reports. 23(4). 45–45. 20 indexed citations

Watson, Adrienne L., et al.. (2021). Spontaneous and Engineered Large Animal Models of Neurofibromatosis Type 1. International Journal of Molecular Sciences. 22(4). 1954–1954. 11 indexed citations

Coutts, Alexander, Barbara R. Tschida, Mark N. Kirstein, et al.. (2021). Selumetinib normalizes Ras/MAPK signaling in clinically relevant neurofibromatosis type 1 minipig tissues in vivo. Neuro-Oncology Advances. 3(1). vdab020–vdab020. 6 indexed citations

Nicholls, Peter K., Hubert Schorle, Sahin Naqvi, et al.. (2019). Mammalian germ cells are determined after PGC colonization of the nascent gonad. Proceedings of the National Academy of Sciences. 116(51). 25677–25687. 79 indexed citations

Rathe, Susan K., Flavia E. Popescu, James E. Johnson, et al.. (2019). Identification of candidate neoantigens produced by fusion transcripts in human osteosarcomas. Scientific Reports. 9(1). 358–358. 31 indexed citations

10.

Carlson, Marjorie, et al.. (2017). Multiphoton fluorescence lifetime imaging of chemotherapy distribution in solid tumors. Journal of Biomedical Optics. 22(11). 1–1. 18 indexed citations

11.

Watson, Adrienne L., Daniel F. Carlson, David A. Largaespada, Perry B. Hackett, & Scott C. Fahrenkrug. (2016). Engineered Swine Models of Cancer. Frontiers in Genetics. 7. 78–78. 47 indexed citations

12.

Moriarity, Branden S., Eric P. Rahrmann, Caitlin B. Conboy, et al.. (2014). Simple and Efficient Methods for Enrichment and Isolation of Endonuclease Modified Cells. PLoS ONE. 9(5). e96114–e96114. 25 indexed citations

13.

Watson, Adrienne L., Vincent W. Keng, Eric P. Rahrmann, et al.. (2014). Co-targeting the MAPK and PI3K/AKT/mTOR pathways in two genetically engineered mouse models of schwann cell tumors reduces tumor grade and multiplicity. Oncotarget. 5(6). 1502–1514. 64 indexed citations

14.

Rahrmann, Eric P., Branden S. Moriarity, George M. Otto, et al.. (2014). Trp53 Haploinsufficiency Modifies EGFR-Driven Peripheral Nerve Sheath Tumorigenesis. American Journal Of Pathology. 184(7). 2082–2098. 27 indexed citations

15.

Watson, Adrienne L., Eric P. Rahrmann, Branden S. Moriarity, et al.. (2013). Canonical Wnt/β-catenin Signaling Drives Human Schwann Cell Transformation, Progression, and Tumor Maintenance. Cancer Discovery. 3(6). 674–689. 76 indexed citations

16.

Rahrmann, Eric P., Adrienne L. Watson, Vincent W. Keng, et al.. (2013). Forward genetic screen for malignant peripheral nerve sheath tumor formation identifies new genes and pathways driving tumorigenesis. Nature Genetics. 45(7). 756–766. 108 indexed citations

17.

Keng, Vincent W., Eric P. Rahrmann, Adrienne L. Watson, et al.. (2012). PTEN and NF1 Inactivation in Schwann Cells Produces a Severe Phenotype in the Peripheral Nervous System That Promotes the Development and Malignant Progression of Peripheral Nerve Sheath Tumors. Cancer Research. 72(13). 3405–3413. 67 indexed citations

18.

Watson, Adrienne L., Hyun-Gwan Lee, Na Zhao, et al.. (2012). Diet and Energy-Sensing Inputs Affect TorC1-Mediated Axon Misrouting but Not TorC2-Directed Synapse Growth in a Drosophila Model of Tuberous Sclerosis. PLoS ONE. 7(2). e30722–e30722. 16 indexed citations

19.

Keng, Vincent W., Adrienne L. Watson, Eric P. Rahrmann, et al.. (2012). Conditional Inactivation ofPtenwithEGFROverexpression in Schwann Cells Models Sporadic MPNST. Sarcoma. 2012. 1–12. 27 indexed citations

20.

Adhikari, Neeta, David L. Basi, DeWayne Townsend, et al.. (2010). Heparan sulfate Ndst1 regulates vascular smooth muscle cell proliferation, vessel size and vascular remodeling. Journal of Molecular and Cellular Cardiology. 49(2). 287–293. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact